TY - JOUR
T1 - A plant triterpenoid, avicin D, induces autophagy by activation of AMP-activated protein kinase
AU - Xu, Z. X.
AU - Liang, J.
AU - Haridas, V.
AU - Gaikwad, A.
AU - Connolly, F. P.
AU - Mills, G. B.
AU - Gutterman, J. U.
N1 - Funding Information:
Acknowledgements. We thank Dr. Craig B Thompson for providing Bax−/− Bak−/− cells, Dr. Kun-Liang Guan for providing AMPK-DN plasmid, Dr. Gaochao Zhou from Merck Research Laboratories for providing compound C. We thank Dr. YL Lu for her helpful discussion. We thank Mr. K Dunner, Jr. and Ms. Shuangxing Yu for the expert technical assistance. This work was supported by the Clayton Foundation for Research, the Biomedical Research Foundation (to JUG), Developmental Research Awards from National Institutes of Health SPORE (P50-CA83639) (to Z.X.X), and MD Anderson Cancer Center Core Grant CA16672 from the National Cancer Institute, which supported the core facilities.
PY - 2007/11
Y1 - 2007/11
N2 - Avicins, a family of plant triterpene electrophiles, can trigger apoptosis-associated tumor cell death, and suppress chemical-induced carcinogenesis by its anti-inflammatory, anti-mutagenic, and antioxidant properties. Here, we show that tumor cells treated with benzyloxycarbonylvalyl-alanyl-aspartic acid (O-methyl)-fluoro- methylketone, an apoptosis inhibitor, and Bax-/- and Bak-/- apoptosis-resistant cells can still undergo cell death in response to avicin D treatment. We demonstrate that this non-apoptotic cell death is mediated by autophagy, which can be suppressed by chloroquine, an autophagy inhibitor, and by specific knockdown of autophagy-related gene-5 (Atg5) and Atg7. Avicin D decreases cellular ATP levels, stimulates the activation of AMP-activated protein kinase (AMPK), and inhibits mammalian target of rapamycin (mTOR) and S6 kinase activity. Suppression of AMPK by compound C and dominant-negative AMPK decreases avicin D-induced autophagic cell death. Furthermore, avicin D-induced autophagic cell death can be abrogated by knockdown of tuberous sclerosis complex 2 (TSC2), a key mediator linking AMPK to mTOR inhibition, suggesting that AMPK activation is a crucial event targeted by avicin D. These findings indicate the therapeutic potential of avicins by triggering autophagic cell death.
AB - Avicins, a family of plant triterpene electrophiles, can trigger apoptosis-associated tumor cell death, and suppress chemical-induced carcinogenesis by its anti-inflammatory, anti-mutagenic, and antioxidant properties. Here, we show that tumor cells treated with benzyloxycarbonylvalyl-alanyl-aspartic acid (O-methyl)-fluoro- methylketone, an apoptosis inhibitor, and Bax-/- and Bak-/- apoptosis-resistant cells can still undergo cell death in response to avicin D treatment. We demonstrate that this non-apoptotic cell death is mediated by autophagy, which can be suppressed by chloroquine, an autophagy inhibitor, and by specific knockdown of autophagy-related gene-5 (Atg5) and Atg7. Avicin D decreases cellular ATP levels, stimulates the activation of AMP-activated protein kinase (AMPK), and inhibits mammalian target of rapamycin (mTOR) and S6 kinase activity. Suppression of AMPK by compound C and dominant-negative AMPK decreases avicin D-induced autophagic cell death. Furthermore, avicin D-induced autophagic cell death can be abrogated by knockdown of tuberous sclerosis complex 2 (TSC2), a key mediator linking AMPK to mTOR inhibition, suggesting that AMPK activation is a crucial event targeted by avicin D. These findings indicate the therapeutic potential of avicins by triggering autophagic cell death.
UR - http://www.scopus.com/inward/record.url?scp=35548996805&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35548996805&partnerID=8YFLogxK
U2 - 10.1038/sj.cdd.4402207
DO - 10.1038/sj.cdd.4402207
M3 - Article
C2 - 17690712
AN - SCOPUS:35548996805
SN - 1350-9047
VL - 14
SP - 1948
EP - 1957
JO - Cell death and differentiation
JF - Cell death and differentiation
IS - 11
ER -